Thomas, Anita http://orcid.org/0000-0002-9653-0393
Necchi, Andrea http://orcid.org/0000-0002-3007-2756
Muneer, Asif
Tobias-Machado, Marcos http://orcid.org/0000-0002-5079-4836
Tran, Anna Thi Huyen
Van Rompuy, Anne-Sophie http://orcid.org/0000-0002-0138-4486
Spiess, Philippe E. http://orcid.org/0000-0002-5723-1972
Albersen, Maarten http://orcid.org/0000-0002-6763-6586
Article History
Accepted: 12 January 2021
First Online: 11 February 2021
Competing interests
: M.A.: eUROGEN clinical lead on rare urogenital cancer workstream (WS3); <i>Nature Reviews Urology</i> advisory board member; <i>European Urology</i> Associate Editor; EAU Scientific Office member; EAU–ASCO penile cancer guideline panel member. A.Th.: EUSP scholar. A.M.: eUROGEN research lead on rare urogenital cancer workstream (WS3); ESMO penile cancer guideline panel member; editorial board <i>BJU International</i>. A.N.: EAU–ASCO penile cancer guideline panel member, penile cancer research funding to institute by Ipsen and Pfizer. P.E.S.: NCCN penile cancer guideline discussion writing committee member; EAU–ASCO penile cancer guideline panel member; <i>Nature Reviews Urology</i> advisory board member. M.T.-M.: coordinator of Penile Cancer Collaborative Coalition – Latin America. All other authors declare no competing interests.